Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-018611

CBO & COO gave up 3,112 shares (to pay taxes)

  • CBO & COO acquired 7,584 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2022-03-10 Option exercise +4,584 26,909 D
Klein Lawrence Otto CBO & COO 2022-03-11 Shares withheld for taxes −1,883 $62.56 $117,800 25,026 D
Klein Lawrence Otto CBO & COO 2022-03-11 Option exercise +3,000 28,026 D
Klein Lawrence Otto CBO & COO 2022-03-14 Shares withheld for taxes −1,229 $61.08 $75,067 26,797 D
Derivatives
Klein Lawrence Otto CBO & COO 2022-03-10 Option exercise · Restricted Stock Units −4,584 4,583 D
Klein Lawrence Otto CBO & COO 2022-03-11 Option exercise · Restricted Stock Units −3,000 9,000 D
Loading xslF345X03/doc4.xml…